MOLLY MONTANYE: Open Payments
NPI 1912381302 · ROCHESTER, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$803 in 32 payments from 13 companies in 2025. Trend: 2023 $245 · 2024 $681 · 2025 $803
Food & beverage: $803
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 1 | $135 |
| Novartis Pharmaceuticals Corporation | 6 | $134 |
| Novo Nordisk Inc | 5 | $92 |
| AstraZeneca Pharmaceuticals LP | 4 | $73 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $65 |
| Inspire Medical Systems, Inc. | 1 | $64 |
| Merck Sharp & Dohme LLC | 3 | $60 |
| SCPHARMACEUTICALS INC. | 2 | $39 |
| Amgen Inc. | 2 | $37 |
| BridgeBio Pharma, Inc. | 2 | $30 |
Products named: EVKEEZA, LEQVIO, Wegovy, JARDIANCE, INSPIRE, FARXIGA, VERQUVO, FUROSCIX.
Industry payments across NY — which companies pay providers there.
